Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Data published on line in the Journal of Urology last December suggest that the new PDE5 inhibitor known as avanafil or Stendra® is supposedly effective in combating erectile dysfunction (ED) in just over one-third of men with ED at 6 months after bilateral, nerve-sparing radical prostatectomy. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: avanafil, ED, efficacy, erectile dysfunction, prostatectomy, safety | 7 Comments »
Data from a large, retrospective, multi-center study of stereotactic body radiation therapy (SBRT) with CyberKnife technology in the treatment of men with localized prostate cancer were presented on Wednesday afternoon at the annual meeting of the American Society for Radiation Oncology (ASTRO). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, efficacy, outcome, radiation, SBRT, stereotactic, therapy | 1 Comment »
A new paper in the Journal of Oncology Practice has attempted to compare the cost-effectiveness of stereotactic body radiation therapy (SBRT) to that of intensity-modulated radiation therapy (IMRT) in the treatment of men with low- to intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: cost, efficacy, IMRT, intermediate risk, localized, low risk, outcome, SBRT | 3 Comments »
There have been an increasing number of articles published in the recent past suggesting salvage cryotherapy as an excellent option for the treatment of men with progressive prostate cancer after failure of first-line radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: cryotherapy, efficacy, outcome, safety, salvage, survival | Leave a Comment »
According to a number of media reports today, Medivation’s investigational drug MDV3100 appears to have a relatively good safety profile, although five patients who received MDV3100 in the completed Phase III trial did have seizures. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: efficacy, mCRPC, MDV3100, Phase III, safety | 6 Comments »
A media release issued yesterday by ASTRO reads as follows: … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, efficacy, outcome, PBRT, proton beam, radiation therapy, safety | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site